These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4412886)

  • 1. Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
    Becker FF; Sell S
    Cancer Res; 1974 Oct; 34(10):2489-94. PubMed ID: 4412886
    [No Abstract]   [Full Text] [Related]  

  • 2. -Fetoprotein and hepatocarcinogenesis in rats fed 3'-methyl-4-(dimethylamino)azobenzene or N-2-fluorenylacetamide.
    Kitagawa T; Yokochi T; Sugano H
    Int J Cancer; 1972 Sep; 10(2):368-81. PubMed ID: 4122310
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated concentrations of serum alpha-fetoprotein in rats with chemically induced liver tumors.
    Kroes R; Sontag JM; Sell S; Williams GM; Weisburger JH
    Cancer Res; 1975 May; 35(5):1214-7. PubMed ID: 47266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of alpha-fetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene.
    Okita K; Gruenstein M; Klaiber M; Farber E
    Cancer Res; 1974 Oct; 34(10):2758-63. PubMed ID: 4370173
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
    Ito N; Farber E
    J Natl Cancer Inst; 1966 Dec; 37(6):775-85. PubMed ID: 4289069
    [No Abstract]   [Full Text] [Related]  

  • 6. Sex differences in cell proliferation and N-hydroxy-2-acetylaminofluorene sulfotransferase levels in rat liver during 2-acetylaminofluorene administration.
    Jackson CD; Irving CC
    Cancer Res; 1972 Jul; 32(7):1590-4. PubMed ID: 5030584
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic controls in precancerous liver. II. Loss of feedback control of cholesterol synthesis, measured repeatedly in vivo, during treatment with the carcinogens N-2-fluorenylacetamide and aflatoxin.
    Horton BJ; Horton JD; Sabine JR
    Eur J Cancer (1965); 1972 Aug; 8(4):437-43. PubMed ID: 4342181
    [No Abstract]   [Full Text] [Related]  

  • 8. Early appearance of serum -fetoprotein as a function of dosage of various hepatocarcinogens.
    Kroes R; Williams GM; Weisburger JH
    Cancer Res; 1973 Mar; 33(3):613-7. PubMed ID: 4120353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF; Fox RA; Klein KM; Wolman SR
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of age and sex on hepatic lesions induced by chemical carcinogens: ingestion of N-4-(4'-fluorobiphenyl)acetamide by Buffalo strain rats.
    Stromberg K; Reuber MD
    J Natl Cancer Inst; 1970 May; 44(5):1047-54. PubMed ID: 5514470
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE; Burns FJ; Bilger L; Gardner D; Troll W
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blastomogenesis in rats in the presence of the combined action of N-2-fluorenylacetamide and N-nitrosodimethylamine].
    Likhachev AIa
    Vopr Onkol; 1969; 15(9):65-9. PubMed ID: 5354750
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of orotic acid on liver tumorigenesis in rats ingesting ethionine, N-2-fluorenylacetamide, and 3'-methyl-dimethylaminoazobenzene.
    Sidransky H; Verney E
    J Natl Cancer Inst; 1970 May; 44(5):1201-15. PubMed ID: 5514477
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined enzyme histochemical and radioautographic studies on areas of hyperplasia in the liver of rats fed N-2-fluorenylacetamide.
    Kitagawa T; Sugano H
    Cancer Res; 1973 Nov; 33(11):2993-3001. PubMed ID: 4355988
    [No Abstract]   [Full Text] [Related]  

  • 15. On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat.
    Weisburger JH; Yamamoto RS; Williams GM; Grantham PH; Matsushima T; Weisburger EK
    Cancer Res; 1972 Mar; 32(3):491-500. PubMed ID: 5061304
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell function: its importance in chemical carcinogenesis.
    Becker FF
    Fed Proc; 1971; 30(6):1736-41. PubMed ID: 4942049
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of alpha1-fetoprotein levels during exposure to 3'-methyl-4-dimethylaminoazobenzene and its analogs.
    Becker FF; Horland AA; Shurgin A; Sell S
    Cancer Res; 1975 Jun; 35(6):1510-3. PubMed ID: 48420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.
    Becker FF
    Cancer Res; 1975 Jul; 35(7):1734-6. PubMed ID: 165882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic effect of testosterone on rat liver tumor induction by N-2-fluorenylacetamide.
    Toh YC
    J Natl Cancer Inst; 1972 Jan; 48(1):113-8. PubMed ID: 4652367
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of 3-methylcholanthrene on liver carcinogenesis in rats ingesting DL-ethionine, 3'-methyl-4-dimethylaminoazobenzene, and N-2-fluorenylacetamide.
    Marugami M; Ito N; Konishi Y; Hiasa Y; Farber E
    Cancer Res; 1967 Nov; 27(11):2011-9. PubMed ID: 4965303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.